Wei, Wei (2016) The Value of Pharmaceutical R&D Projects under Uncertainty and Drug Approval Policy. PhD thesis, University of York.
Abstract
Pharmaceutical R&D projects often have the characteristics of irreversibility on investment, flexibility of investment timing, and uncertainty in cash flows. In this thesis, the real options approach is used as the evaluation tool for these projects and three continuous-time investment models are developed. In chapter 4, we discuss the effects of the investment lag and commercialization flexibility on the investment decisions under uncertainty. Chapter 5 examines which organizational structures, the decentralized or centralized pharmaceutical R&D project, are more socially desirable in terms of early investment and higher project value. Chapter 6 considers whether adding a time constraint on the drug development process will increase the investment incentives and how remuneration level will influence the quality of the products, as well as the timing of commercialization.
Metadata
Supervisors: | Thijssen, Jacco |
---|---|
Keywords: | Real Options, Uncertainty |
Awarding institution: | University of York |
Academic Units: | The University of York > Economics and Related Studies (York) |
Identification Number/EthosID: | uk.bl.ethos.721891 |
Depositing User: | Mr Wei Wei |
Date Deposited: | 09 Aug 2017 14:16 |
Last Modified: | 24 Jul 2018 15:22 |
Open Archives Initiative ID (OAI ID): | oai:etheses.whiterose.ac.uk:17815 |
Download
Examined Thesis (PDF)
Filename: Thesis revised version (Wei Wei).pdf
Licence:
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License
Export
Statistics
You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.